Investing

0 1237
Synergy Pharmaceuticals SGYP Stock News

Synergy Pharmaceuticals Inc (NASDAQ: SGYP)

Synergy Pharmaceuticals wasn’t having the best of days in the market today. In fact, the stock started the day off in the red and continued on a slow, yet steady decline throughout the trading session, closing the day in the red. However, we’re seeing a spike in after-hours. Below, we’ll talk about what we’re seeing, why, and what we’ll be watching for with regard to SGYP ahead.





What We’re Seeing From SGYP

As mentioned above, Synergy Pharmaceuticals didn’t have what anyone would consider to be a good day in the market today. When the trading session opened, the stock was trading slightly in the red. However, after slow, yet steady downward movement all day, the declines became something worth looking at. By the close of the day, the stock was trading at $6.41 per share after a loss of $0.12 per share, or 1.84%. However, in the first minutes of after-hours trading, the stock is spiking. At the moment (4:06), SGYP is trading at $6.85 per share after a gain of $0.44 per share (6.86%) thus far.

Why The Stock Is Spiking

As soon as our partners at Trade Ideas sent us the alert that SGYP was spiking, the CNA Finance team started working to see why. It didn’t take long for us to dig up this story, and it’s a big one. It seems as though the gains are being caused by news surrounding one of the New Drug Applications the company has been waiting on.


Minutes ago, it was announced that the United States Food and Drug Administration has approved Synergy Pharmaceuticals’ Plecanatide for the treatment of Chronic Idiopathic Constipation, also known as CIC. This approval is a massive milestone for the company, and investors are reacting. After all, this means that the company will now be able to move Plecanatide to the commercial stage.

What We’ll Be Watching For Ahead

Moving forward, the CNA Finance team will be keeping a close eye on SGYP. Now that the company has received the approval it needs, we’re interested in seeing what the next steps are. We’ll be following the news closely and bringing it to you as it breaks!

Update – SGYP has reversed in a big way on a severe diarrhea warning associated with approval.

Never Miss The News Again

Do you want real-time, actionable news delivered to your inbox? Join the CNA Finance mailing list below!

Subscribe Today!

* indicates required










[Image Courtesy of Pixabay]

0 530
Perrigo PRGO Stock News

Perrigo (NYSE: PRGO)

Perrigo was having a relatively normal trading session in the market today. When the opening bell rang, the stock was in the red. However, throughout the day, we saw slow gains, bringing it to the green. Nothing about the movement was too exciting. Then, minutes ago, things changed as the stock started to spike toward the top. Below, we’ll talk about what we’re seeing from PRGO, why, and what we’ll be watching for ahead.





What We’re Seeing From PRGO

As mentioned above, Perrigo was having a relatively normal day in the market today. When the opening bell rang, the stock found itself slightly in the red. After a slow moving day of mostly upward movement, the stock made it to the green. However, nothing about the movement was worth writing home about. At the moment, that’s not the case. Minutes ago, things changed in a big way as the stock started spiking upward. Currently (11:16), PRGO is trading at $77.37 per share after a gain of $0.91 per share (1.19%) thus far today.

Why The Stock Is Spiking Upward

Our partners at Trade Ideas were the first to notify us of the spike on PRGO. As soon as they did, the CNA Finance team started digging to see exactly what was behind the movement. In this case, it didn’t take long to dig up the fake news story behind the whole thing. Ultimately, the spike is being caused by rumors that the company will be acquired, started by a fake news post.


The rumor suggests that Teva will be taking Perrigo over, and that’s an exciting idea for many. However, don’t get your hopes up. The rumor first broke on the infamous website Intereconomia. The website is known for publishing fake reports about potential takeovers and pumping a stock up. Of course, this is likely so they and their friends can profit from the movement. The rumor is not true. TEVA will not be acquiring PRGO.

What We’ll Be Watching For Ahead

Moving forward, the CNA Finance team will be watching PRGO closely. In most cases with these rumors, we’re watching for validity to the claims. In this case, we’re not. We know that if Intereconomia breaks the story, it’s garbage, it’s a rumor, it’s not true! So, we’ll be watching to see the reaction in the market when the masses see that reality.

Never Miss The News Again

Do you want real-time, actionable news delivered to your inbox? Join the CNA Finance mailing list below!

Subscribe Today!

* indicates required










CIGNA CI Stock News

CIGNA Corporation (NYSE: CI)

CIGNA wasn’t off to the best of days in the market today. In fact, the stock was trading well into the red when the trading session opened. Through the morning, it eventually made it back up to the breakeven point, only to lay flat for a while and then start falling again. However, minutes ago, the stock started spiking upward in a big way. Below, we’ll talk about what we’re seeing from CI, why, and what we’ll be watching for ahead.





What We’re Seeing From CI

As mentioned above, today wasn’t looking like it was going to be a great one for CIGNA early on in the session. Unfortunately, the stock started the day in the red, and while it fought to get back to the breakeven point, it seemed as though it was destined to land red for the day. That is, until minutes ago when the stock started spiking. Currently (10:53), CI is trading at $145.65 per share after a gain of $3.89 per share (2.74%) thus far today.

Why The Stock Is Headed Up

Our partners at Tradespoon were the first to inform us of the spike on CI. As soon as they did, the CNA Finance team started digging to see what was causing the movement. In this case, the answer to our question was found on Twitter. At the moment, the merger between CIGNA and Anthem looks like it may hit a snag.


A message on Twitter pointed out that the New York Post says that it sees the merger being blocked. While many agreed with the merger, many were against it as well. Nonetheless, it’s not over until the figurative fat lady sings, and we’re nowhere near that point just yet.

What We’ll Be Watching For Ahead

Moving forward, the CNA Finance team will be watching the story surrounding the potential merger between CI and ANTM incredibly closely. While it looks like it may have hit a snag, nothing is final quite yet. We’ll be watching the news closely and bringing it to you as it breaks!

Never Miss The News Again

Do you want real-time, actionable news delivered to your inbox? Join the CNA Finance mailing list below!

Subscribe Today!

* indicates required










[Image Courtesy of Geograph]

Michael Kors Holdings Ltd KORS Stock News

Michael Kors Holdings Ltd (NYSE: KORS)

Michael Kors Holdings wasn’t off to the best of days in the market today. In fact, the stock was trading slightly in the red at the opening bell. From there, it continued downward, falling further and further into the abyss before finding support. However, minutes ago, things changed in a big way as the stock started spiking upward. Below, we’ll talk about what we’re seeing, why, and what we’ll be watching for with regard to KORS ahead.





What We’re Seeing From KORS

As mentioned above, Michael Kors Holdings was off to what seemed like it was going to be a rough trading session early on. When the session started, the stock was already trading on slight losses. From there, it continued to head downward for the first half hour or so before finding support. However, minutes ago, the stock started screaming upward, making its way cleanly into the green. At the moment (10:17), KORS is trading at $43.39 per share after a gain of $0.16 per share (0.37%) thus far today.

Why The Stock Is Spiking

Our partners at Trade Ideas were the first to inform us of the gains on KORS. As soon as they did, the CNA Finance team went to work to see exactly why the stock was spiking in the upward direction. It didn’t take long to uncover the story. In our search, we were unable to find anything fundamental that would have caused such a spike. However, we were able to find a rumor that we believe is the cause of the movement.


At the moment, all over social media, there’s a rumor surfacing about Michael Kors Holdings. That rumor is that the company is likely to be taken over soon. At the moment, the rumor is unconfirmed. Honestly, this isn’t the only time we’ve seen this on KORS. In fact, in the past few months, I remember seeing a rumor like this surrounding KORS at least 3 times! So, I wouldn’t get my hopes up if I were you.

What We’ll Be Watching For Ahead

Moving forward, the CNA Finance team will be keeping a close eye on KORS. In particular, we’ll be watching to see if the rumor actually comes to fruition in this case. While it would be great for shareholders, we don’t believe that it will actually happen. At the end of the day, takeover rumors to KORS are like user growth issues to TWTR, they happen all the time! Nonetheless, we’ll be watching the story and bringing it to you as it breaks!

Never Miss The News Again

Do you want real-time, actionable news delivered to your inbox? Join the CNA Finance mailing list below!

Subscribe Today!

* indicates required










[Image Courtesy of Wikimedia]

3D Systems Corporation DDD Stock News

3D Systems Corporation (NYSE: DDD)

3D Systems is off to what seems to be an incredible day in the market today. When the opening bell rang, the stock was trading close to the breakeven point. However, since then, the stock has been screaming upward. Below, we’ll talk about what we’re seeing from DDD, why, and what we’ll be watching for ahead.





What We’re Seeing From DDD

As mentioned above, 3D Systems is having an incredible day in the market thus far today. The stock started the day off very close to the breakeven point. However, it went on a mad dash toward the top as soon as the bell rang. From there, we’ve seen a continuation of strong upward movement. At the moment (9:48), DDD is trading at $16.93 per share after a gain of $0.83 per share (5.16%) thus far today.

Why The Stock Is Spiking Upward

In the case of DDD, our partners at Tradespoon were the first to alert us to the upward movement. As soon as they did, the CNA Finance team started digging to see exactly what was causing the movement. In this case, it didn’t take long to dig up the reason for the spike. While we were unable to find any fundamental news with regard to the company, the gains seem to be the result of a rumor.


At the moment, there’s a big rumor surrounding 3D Systems in the social media realm. That rumor is that the company is likely to be taken over soon. While this is definitely exciting investors given the gains we’ve seen so far today, it’s important to remember that this is nothing more than an unconfirmed rumor that could be debunked at any moment!

What We’ll Be Watching For Ahead

Moving forward, the CNA Finance team will be keeping a close eye on DDD. In particular, we’re interested in learning if there is any validity to the rumor that the company is going to be acquired. Of course if there is, this could prove to be massive news for shareholders. We’ll keep an eye on the news and bring it to you as it breaks!

Never Miss The News Again

Do you want real-time, actionable news delivered to your inbox? Join the CNA Finance mailing list below!

Subscribe Today!

* indicates required










[Image Courtesy of Wikipedia]

0 605
Mallinckrodt PLC MNK Stock News

Mallinckrodt PLC (NYSE: MNK)

Mallinckrodt wasn’t having an incredibly exciting day in the market today. Like most stocks it seems today, it started the day off near the break even point and has traded relatively flat since. However, minutes ago, things changed in a big way. Unfortunately, the stock took a big dive. Below, we’ll talk about what we’re seeing from MNK, why, and what we’re going to be watching for ahead.





What We’re Seeing From MNK

As mentioned above, Mallinckrodt wasn’t off to the best or worst of days today in the market. When the opening bell rang, the stock found itself relatively flat, and stayed that way throughout the day. Sure, there were some times in the green and some times in the red, but nothing was worth writing home about. Nonetheless, that changed minutes ago as the stock started to fall like a brick from the Empire State Building. At the moment (2:28), MNK is trading at $44.76 per share after a loss of $4.66 per share or 9.43% thus far today.

Why The Stock Is Falling

In this particular case, our partners at Tradespoon were the first to notify us of the movement on MNK. When they did, the CNA Finance team started digging to see exactly what was causing the decline in the stock. In this case, it took no time at all. It looks like bankruptcy may be on its way for the company as the FTC takes a look.

Minutes ago, the story started breaking. The United States Federal Trade Commission is currently in the process of preparing charges against Mallinckrodt. The charges surround the company allegedly using its monopoly to jack up the price of a drug that is used to treat Lupus as well as multiple sclerosis. The price increased 2165% to its current price of about $28,000 per dose.

What We’ll Be Watching For Ahead

Moving forward, the CNA Finance team will be watching MNK incredibly closely. In particular, we’re interested in learning more about the charges that will be filed and learning about the company’s defense to such charges. Nonetheless, we’ll be watching the news closely and bringing it to you as it breaks!

Update: MNK is halted with “news pending”. We know the news… it’s not good! Of course, they haven’t made it formal yet. We’ll be following the story!

Update: There are now reports surfacing that the Obama Administration is planning on filing suit against Mallinckrodt in its final days.

Update: A rumor has emerged that MNK is already ready to announce a settlement with the FTC. The rumor is unconfirmed. The stock remains halted.

Update: It’s official, the company has made a statement saying that it has responded to the FTC with a settlement.

Update: MNK reopens higher, surprisingly in the green for the day. Currently (3:27), the stock is trading at $50.00 per share after a gain of $0.58 per share or 1.17% thus far. This is a wild ride.

 Update: An unconfirmed rumor has it that the company has made a settlement offer at $100 million. If that’s the case, that represents more than 1/3 of the $280.5 million the company has on hand. Mixed with the $6 billion in debt, things aren’t looking good.
Update: It has been confirmed. MNK has settled for a total of $100 million. Here’s the link to the FTC statement.
Update – Part of the settlement requires MNK to license rights to a generic alternative to Acthar.

Never Miss The News Again

Do you want real-time, actionable news delivered to your inbox? Join the CNA Finance mailing list below!

Subscribe Today!

* indicates required










[Image Courtesy of Wikimedia]

Mead Johnson Nutrition Co MJN Stock News

Mead Johnson Nutrition Co (NYSE: MJN)

Mead Johnson Nutrition has had a relatively normal day in the market thus far. When the opening bell rang, the stock fell slightly red. Throughout the day, we’ve seen a series of up and down movement, but nothing worth writing home about. Nonetheless, minutes ago, that all changed. The stock is now spiking toward the sky. Below, we’ll talk about what we’re seeing from MJN, why, and what we’ll be watching for ahead.





What We’re Seeing From MJN

As mentioned above, Mead Johnson Nutrition wasn’t having the most exciting of days in the market today. At the open, the stock went slightly red, eventually making it back to the green and bouncing around with small movements above and below the line. However, that all changed minutes ago as the stock started spiking toward the sky. Currently (1:56), MJN is trading at $73.83 per share after a gain of $2.39 per share (3.35%) thus far today.

Why The Stock Is Spiking

In this case, our partners at Trade Ideas were the first to bring us the alert that MJN was spiking. As soon as they did, the CNA Finance team went to work to dig up exactly what happened that caused the spike. It didn’t take long to find the story. It seems as though there’s some pretty valid takeover chatter happening on the stock at the moment.


According to a recent Street Insider report, Nestle is considering taking over the company. Of course, this is not your normal rumor. This is a very valid report. If Nestle sees a strong value here, an acquisition will likely happen. Of course, if that’s the case, tremendous value would be returned to shareholders.

What We’ll Be Watching For Ahead

Moving forward, the CNA Finance team will be keeping a close eye on MJN. In particular, we’ll be watching to see if Nestle does indeed decide to make a takeover offer, and if so, what price the offer will carry.  This is likely to get interesting quickly. We’ll be following the news and bringing it to you as it breaks!

Update: Rumor has it that JPM will soon dismiss this rumor as unlikely.

Never Miss The News Again

Do you want real-time, actionable news delivered to your inbox? Join the CNA Finance mailing list below!

Subscribe Today!

* indicates required










[Image Courtesy of Wikimedia]

0 392
YY Inc YY Stock News

YY Inc (ADR) (NASDAQ: YY)

YY Inc was having what seemed to be a good day in the market, but it was a relatively normal one. At the opening bell, the stock was slightly in the green. Throughout the day, the stock saw ups and downs, but the trend overall was positive. Nonetheless, things changed in a big way minutes ago as the stock started to spike. Below, we’ll talk about what we’re seeing from YY, why, and what we’ll be watching for ahead.





What We’re Seeing From YY

As mentioned above, YY Inc was off to what seemed to be a relatively normal trading session. While the stock has been in the green all day, and the trend has more or less been a positive one, there really wasn’t much excitement surrounding the movement. However, that’s not the case at the moment. Minutes ago, the stock started spiking! At the moment (12:21), YY is trading at $45.10 per share after a gain of $2.07 per share (4.81%) thus far today.

Why The Stock Is Spiking

Our partners at Trade Ideas first alerted us of the spike higher on YY. As soon as they did, the CNA Finance team started digging to see what was causing the movement. In this case, it didn’t take long to uncover the story. While the company has released no fundamental news that would lead to such gains, there is a rumor surfacing that’s likely the cause.


At the moment, regardless of what your favorite social network might by, if you search for YY Inc, you’ll likely find the rumor. The rumor is that Alibaba is interested in taking over the company and may be making a bid soon. While this rumor is largely unconfirmed at the moment, the nature of the rumor is a bit different from what we normally see, so this might be a real takeover in the works my friends!

What We’ll Be Watching For Ahead

Moving forward, the CNA Finance team will be keeping a close eye on YY. In particular, we’ll be watching to see if the rumors are true and what Alibaba’s bid might be. If it is true, the implications could be huge for shareholders. We’ll watch the story closely and bring the news to you as it develops!

Never Miss The News Again

Do you want real-time, actionable news delivered to your inbox? Join the CNA Finance mailing list below!

Subscribe Today!

* indicates required










[Image Courtesy of Wikimedia]

0 1524
Juno Therapeutics Inc JUNO Stock News

Juno Therapeutics Inc (NASDAQ: JUNO)

Juno Therapeutics was having what started off as a normal day in the market today. While the stock started the day off in the green, it quickly made its way down to the red. From there, we saw quite a bit of movement on both sides of the line as the day progressed. However, minutes ago, the stock started spiking upward in a big way. Below, we’ll talk about what we’re seeing from JUNO, why, and what we’ll be watching for ahead.





What We’re Seeing From JUNO

As mentioned above, Juno Therapeutics wasn’t having an amazing day in the market by any means. With plenty of time both above and below the breakeven point throughout the morning, the stock was having an average day in the market. However, minutes ago, that all changed as the stock started spiking upward. At the moment (11:27), JUNO is trading at $19.41 per share after a gain of $0.33 per share (1.72%) thus far today.

Why The Stock Is Spiking

As soon as the CNA Finance team received the alert from Tradespoon that JUNO was spiking, we started digging to find the reason for the movement. In this case, we were unable to find any fundamental news released by the company. However, when we started digging through social media, the reason for the spike became clear.


A rumor is circling Juno Therapeutics in the world of social media at the moment. That rumor is that the company will be taken over. However, as with most of these rumors, there is no buyer, no confirmation, and not one insinuation of validity. So, in this particular case, we’d say don’t get your hopes up. Nonetheless, it is indeed what’s causing the movement.

What We’ll Be Watching Ahead

Moving forward, the CNA Finance team will be keeping a close eye on JUNO. In particular, we’re interested in learning if there is any validity to this rumor. If it is true, it could return incredible value to shareholders. However, we don’t see this one as being very credible at this point. Nonetheless, we’ll watch the story closely and bring it to you as it develops!

Never Miss The News Again

Do you want real-time, actionable news delivered to your inbox? Join the CNA Finance mailing list below!

Subscribe Today!

* indicates required










[Image Courtesy of Pixabay]

OneBeacon Insurance Group, Ltd. OB Stock News

OneBeacon Insurance Group, Ltd. (NYSE: OB)

OneBeacon Insurance Group was off to what seemed to be a relatively normal day in the market today. After starting in the red at the start of the session, the stock went on a steady path for the green. From there, we’ve seen a continuation of slow, yet steady movement, but nothing that would be considered exciting. However, minutes ago, that all changed as the stock spiked upward. Below, we’ll talk about what we’re seeing from OB, why, and what we’ll be watching for ahead.





What We’re Seeing From OB

As mentioned above, OneBeacon was off to a normal day in the market at the open today. When the bell rang, the stock started slightly in the red. Throughout the day, we’ve seen slow, yet steady movement, pushing the stock in the green and beyond. Nonetheless, nothing about it was exciting. That is, until minutes ago when the stock started spiking upward in a big way. Currently (11:31), OB is trading at $16.80 per share after a gain of $1.64 per share (10.82%) thus far today.

Why The Stock Is Climbing

Our partners at Trade Ideas were the first to notify us of the spike on OB. As soon as they did, the CNA Finance team started digging to see exactly what was causing the movement. In this case, it didn’t take long to find the story. In fact, the movement seems to be the result of a Bloomberg report that was released just minutes ago.


In the report, Bloomberg says that OneBeacon Insurance Group is currently exploring the possibility of being acquired. Of course, if the company is indeed sold, shareholders would likely receive tremendous value, as acquisitions tend to happen at strong premiums. As a result, the stock is spiking!

What We’ll Be Watching For Ahead

Moving forward, the CNA Finance team will be keeping a close eye on OB. In particular, we’ll be watching for news associated with this potential acquisition. This could be a big win for all investors involved. We’ll watch the news closely and bring it to you as it breaks!

Never Miss The News Again

Do you want real-time, actionable news delivered to your inbox? Join the CNA Finance mailing list below!

Subscribe Today!

* indicates required










[Image Courtesy of Wikipedia]

Thought Leader Discussions

Josh Disbrow head shot1 (1)

0 1412
Aytu Bioscience Inc (OTCMKTS: AYTU) Recently, the CNA Finance team had an opportunity to speak with Josh Disbrow, CEO of Aytu Bioscience. Josh Disbrow has...